Physician Wealth Advisors’s Blueprint Medicines BPMC Stock Holding History

Physician Wealth Advisors’s Portfolio BPMC Stock Details BPMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-9	Closed	-$1.15K	–	1923
2025 Q2	$1.15K	Buy	9 +2	+29%	+$208	﹤0.01%	1302
2025 Q1	$620	Buy	+7	New	+$683	﹤0.01%	1332

Other funds holding BPMC

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Physician Wealth Advisors's BPMC Position: Q3 2025 in Review

Physician Wealth Advisors sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 9 shares — an estimated $1.15K sold.

Physician Wealth Advisors first reported a position in BPMC in Q1 2025 and held it in 2 quarters. The position peaked at $1.15K in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

Physician Wealth Advisors reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
Physician Wealth Advisors sold 9 Blueprint Medicines shares in Q3 2025, an estimated $1.15K.
Physician Wealth Advisors first reported a position in Blueprint Medicines in Q1 2025 and held it in 2 quarters.
Physician Wealth Advisors's Blueprint Medicines position peaked at $1.15K in Q2 2025.
5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Physician Wealth Advisors's 13F filing for Q3 2025, filed 4 Nov 2025.